KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 1 filers reported holding KALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $15,007,000 | +14.1% | 10,874,613 | 0.0% | 0.33% | +40.9% |
Q4 2021 | $13,158,000 | -53.8% | 10,874,613 | 0.0% | 0.23% | -41.3% |
Q3 2021 | $28,491,000 | -50.6% | 10,874,613 | 0.0% | 0.40% | -57.3% |
Q2 2021 | $57,635,000 | -21.4% | 10,874,613 | 0.0% | 0.92% | -16.3% |
Q1 2021 | $73,295,000 | -0.6% | 10,874,613 | 0.0% | 1.10% | +7.2% |
Q4 2020 | $73,730,000 | -9.6% | 10,874,613 | 0.0% | 1.03% | -30.9% |
Q3 2020 | $81,560,000 | -28.6% | 10,874,613 | 0.0% | 1.49% | -33.0% |
Q2 2020 | $114,292,000 | +19.6% | 10,874,613 | 0.0% | 2.23% | -26.2% |
Q1 2020 | $95,588,000 | +470.9% | 10,874,613 | +139.7% | 3.02% | +494.3% |
Q4 2019 | $16,743,000 | -3.0% | 4,537,478 | 0.0% | 0.51% | -50.6% |
Q3 2019 | $17,265,000 | -40.4% | 4,537,478 | 0.0% | 1.03% | -33.8% |
Q2 2019 | $28,949,000 | -22.9% | 4,537,478 | 0.0% | 1.55% | -4.0% |
Q1 2019 | $37,525,000 | +69.1% | 4,537,478 | 0.0% | 1.62% | +25.2% |
Q4 2018 | $22,188,000 | +6.4% | 4,537,478 | +114.7% | 1.29% | +15.9% |
Q3 2018 | $20,858,000 | -28.1% | 2,113,236 | 0.0% | 1.12% | -40.8% |
Q2 2018 | $29,015,000 | -13.3% | 2,113,236 | 0.0% | 1.88% | -26.5% |
Q1 2018 | $33,453,000 | -14.4% | 2,113,236 | 0.0% | 2.56% | -21.6% |
Q4 2017 | $39,074,000 | -19.0% | 2,113,236 | 0.0% | 3.27% | -25.0% |
Q3 2017 | $48,266,000 | – | 2,113,236 | – | 4.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 1 | $9 | 0.00% |